
5-Amino-1MQ10 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
5-Amino-1MQ, explained simply
A small synthetic molecule studied in metabolic research. It is often listed alongside peptides, although it is not chemically a peptide.
Research area
Fat metabolism and cellular energy
How it works
Inhibits NNMT, an enzyme involved in nicotinamide metabolism and cellular NAD+ availability.
Why it matters
Researchers are investigating its relationship with fat metabolism and body composition.
What has been observed
In preclinical models, NNMT inhibition has been associated with changes in energy metabolism and fat mass. The same effects have not been established in people.
Effects and points to consider
Reported effects include possible injection-site reactions, headache and temporary nervousness. Long-term human safety data remain limited.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg 5-Amino-1MQ |
|---|---|
| Final volume | 2 mL |
| Concentration | 5 mg/mL |
| One U-100 unit | 50 mcg in 0.01 mL |
Subcutaneous Protocol (2 mL = 5 mg/mL)
| Phase | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Days 1–2 (Tolerance) | 2.5 mg (2500 mcg) | 50 units (0.50 mL) |
| Days 3+ (Standard) | 5 mg (5000 mcg) | 100 units (1.00 mL) |
| Alternative BID | 2.5 mg twice daily | 50 units (0.50 mL) × 2 |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.